Compare iShares Russell 2000 ETF (IWM) vs 10X Genomics Inc (TXG) Price & Performance

IWM, tracking the Russell 2000 small-cap index, trades at $292.34, down 0.6% on the day. Technical indicators show a bullish bias with moving averages supporting an uptrend, while oscillators are neutral. Recent news highlights strong small-cap outperformance, with the Russell 2000 up approximately 20% year-to-date, fueled by institutional inflows and a shifting interest rate outlook.

The outlook for IWM is positive, driven by potential for continued small-cap leadership amid economic expansion and lower rate expectations. Key risks include higher volatility relative to large-caps and sensitivity to broader economic conditions. The ETF offers diversified exposure to nearly 2,000 small-cap stocks, but investors should weigh its 0.19% expense ratio against alternatives.

TXG trades at $47.20, up 7.91% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue that beat estimates, and net losses have narrowed significantly from -$255M in 2023 to -$44M in 2025. Operating cash flow turned strongly positive at $136M in 2025. Recent developments include the acquisition of Proteintech Genomics and a collaboration with Cleveland Clinic on bladder cancer diagnostics.

The outlook is mixed; improving fundamentals and strategic expansions support growth, but persistent net losses and a high EV/EBITDA of 133.91 pose valuation risks. Analyst consensus is divided with a $39.14 price target below the current price, indicating caution despite a majority buy/hold ratings.